Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01643122 · ClinicalTrials.gov registry record
Validation Study for Endometriosis PRO
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 275
- Enrollment target
NCT01643122: Completed study, sponsored by Bayer.
NCT01643122 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 275 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01643122 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 275 participants
- Enrollment target
Study Summary
Assess the psychometric properties of the Endometriosis Symptom Diary (ESD) and the Endometriosis Impact Scale (EIS) and provide evidence whether the PRO measures are reliable, valid and able to detect changes over time in approximately 250 patients with mild, moderate or severe endometriosis confirmed by laparoscopy.
Interventions
- OTHER No drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-09 |
What the finished NCT01643122 record still lists
NCT01643122 is an observational study that tracks outcomes without assigning an intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No drug is the first listed.
NCT01643122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01643122 about?
NCT01643122 is a clinical study titled "Validation Study for Endometriosis PRO". Assess the psychometric properties of the Endometriosis Symptom Diary (ESD) and the Endometriosis Impact Scale (EIS) and provide evidence whether the PRO measures are reliable, valid and able to detect changes over time in approximately 250 patients with mild, moderate or severe endometriosis confir...
What is the current status of trial NCT01643122?
This trial is currently completed. The enrollment target is 275 participants. The study started on 2012-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01643122?
The interventions under investigation include: No drug (OTHER).
Who is sponsoring clinical trial NCT01643122?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia